CHPF2 Antikörper (N-Term)
Kurzübersicht für CHPF2 Antikörper (N-Term) (ABIN7188667)
Target
Alle CHPF2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- CHPF2 Antibody
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the N-terminal region of Human CSGlcA-T.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CHPF2 (Chondroitin Polymerizing Factor 2 (CHPF2))
-
Andere Bezeichnung
- CHPF2
-
Hintergrund
- Chondroitin glucuronyltransferase antibody, Chondroitin polymerizing factor 2 antibody, Chondroitin sulfate glucuronyltransferase antibody, Chondroitin synthase 3 antibody, ChPF-2 antibody, CHPF2 antibody, CHPF2_HUMAN antibody, ChSy 3 antibody, ChSy-3 antibody, CSGLCA T antibody, CSGlcA-T antibody, N acetylgalactosaminyl proteoglycan 3 beta glucuronosyltransferase antibody, N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase antibody
-
UniProt
- Q9P2E5
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-